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Background. In Senegal, Chikungunya virus (CHIKV), which is an emerging mosquito-borne alphavirus, circulates in a syl-
vatic and urban/domestic cycle and has caused sporadic human cases and epidemics since 1960s. However, the real impact of the 
CHIKV sylvatic cycle in humans and mechanisms underlying its emergence still remains unknown.
Methodology. One thousand four hundred nine suspect cases of CHIKV infection, recruited from 5 health facilities located in 
Kedougou region, south-eastern Senegal, between May 2009 to March 2010, together with 866 serum samples collected from school-
children from 4 elementary schools in May and November 2009 from Kedougou were screened for anti-CHIKV immunoglobulin 
(Ig)M antibodies and, when appropriate, for viral nucleic acid by real-time polymerase chain reaction (rPCR) and virus isolation. In 
addition, mosquitoes collected in the same area from May 2009 to January 2010 were tested for CHIKV by rPCR and by virus isola-
tion, and 116 monkeys sera collected from March 2010 to May 2010 were tested for anti-CHIKV IgM and neutralizing antibodies.
Results. The main clinical manifestations of the CHIKV suspect cases were headache, myalgia, and arthralgia. Evidence for 
CHIKV infection was observed in 1.4% (20 of 1409) of patients among suspect cases. No significant difference was observed among 
age or sex groups. In addition, 25 (2.9%) students had evidence of CHIKV infection in November 2009. Chikungunya virus was 
detected in 42 pools of mosquitoes, mainly from Aedes furcifer, and 83% of monkeys sampled were seropositive.
Conclusions. Our findings further documented that CHIKV is maintained in a sylvatic transmission cycle among monkeys and 
Aedes mosquitoes in Kedougou, and humans become infected by exposure to the virus in the forest.
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Chikungunya virus (CHIKV) is a member of the Semliki 
Forest virus antigenic group of the genus Alphavirus (family 
Togaviridae) and was first isolated in 1953 in Tanzania [1, 2]. 
This arthtrogenic virus is composed of 2 lineages: African and 
Asiatic. When symptomatic, cute CHIKV infection in human 
can cause a flu-like syndrome with rash, but joint pains are the 
dominant complaint and might evolve to persistent and inca-
pacitating manifestations. In Africa, CHIKV is maintained in 
nature among nonhuman primates and forest-dwelling Aedes 
sp. In rural areas, these sylvatic vectors can be responsible for 
sporadic cases or small outbreaks [3, 4]. In urban areas, CHIKV 
is transmitted to humans by Aedes aegypti and Aedes albopictus 
[5]. Several studies have reported CHIKV circulation in West 
Africa, especially in Nigeria between 1963 and 1977 [6, 7]. 
Major CHIKV epidemics were recently reported in Africa and 
Asia [8]. A significant outbreak occurred in Italy in 2007, and 
numerous imported cases have been detected elsewhere in 
Europe and the United States of America [9–13], emphasizing 
CHIKV as a re-emerging public health threat worldwide.
In Senegal, CHIKV was first isolated in 1962 from bats 
[14, 15], and CHIKV outbreaks and sporadic cases were sub-
sequently reported in 1966, 1982, 1996, 1997, and 2004–2006 
[4, 16, 17] (Figure 1). In addition, CHIKV has been repeatedly 
isolated from wild caught Aedes furcifer, Aedes luteocephalus, 
and Aedes taylori in a sylvatic focus near Kedougou in south-
eastern Senegal [5, 18–20] as part of an entomological surveil-
lance programme that began in 1972 [21]. Various vertebrates, 
including monkeys, bats, gophers, and galagos, have been 
proven for implication as hosts of CHIKV by serological evi-
dence or viral isolation [5]. Amplifications of CHIKV in the 
Kedougou area have occurred at approximately 5-year intervals, 
which is hypothesized to be the time necessary for the turno-
ver of susceptible vertebrate hosts [5]. Despite active circulation 
of CHIKV in the sylvatic cycle in Senegal, limited informa-
tion is available on its transmission on human and wildlife 
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populations. To address this question, we conducted passive 
surveillance for CHIKV infection among patients attending 5 
health clinics with febrile illness, together with active surveil-
lance of students recruited from 4 schools in Kedougou. In a 
parallel effort, we also investigated monkey serosampling in 
the region and surveyed mosquitoes in the area for CHIKV. In 
this study, we report the investigation of the CHIKV zoonotic 
amplification that occurred among monkeys, mosquitoes, and 
humans in the Kedougou region by 2009–2010.
MATERIALS AND METHODS
Ethics Statement
The protocols for human and monkey studies were approved by 
the National Ethics Committee of Senegal and the University of 
Texas Medical Branch Institutional Review Board and Animal 
Care and Use Committees, respectively. The protocol used for 
animals adheres to the Senegal national guideline and approved 
by the Institutional Review Board of the Interstate School for 
science and veterinary medicine. Written informed consent 
for adults and children was obtained. Concerning children, 
sera were collected with the consent of the parents. An audit 
of the protocol implementation was regularly conducted by the 
authorities of the National Ethics Committee of Senegal.
Study Areas
The study was conducted in the Kedougou region of southeast-
ern Senegal (12°32’N, 12°11’W) (Figure 2). The human popula-
tion is 133 487 inhabitants with an average density of 8 persons 
per km2, 55% of whom are under 20 years of age. The climate 
is Sudano-Guinean with a single rainy season extending from 
May to November. The landscape consists of wooded grassland 
or woodland and dense gallery forest. The average annual tem-
perature is 28.2°C. The main economic activity in the region is 
agriculture and livestock, but hunting and logging are a source of 
human contact with the forest. Currently, gold mining is expand-
ing as one of the most important economic activities in the area.
Human Surveillance
Passive human surveillance focused on patients who attended 
local health facilities for acute febrile illness, and active sur-
veillance involved the periodic seromonitoring of a prospec-
tive cohort of schoolchildren living in the Kedougou region. 
All patients were interviewed by experienced public health 
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Figure 1. Map of Senegal showing locations where Chikungunya outbreaks have been reported. Red circle indicates the localities and the years of Chikungunya virus 
outbreaks.
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workers. The clinical manifestations and demographic data 
were recorded for each patient on a standardized interview 
form. In addition, similar data were obtained from both the 
healthy nonsymptomatic and febrile students.
Passive Surveillance of Chikungunya in Health Facilities
Five healthcare facilities located in Kedougou region were 
selected for human surveillance, including the Ninefesha 
Hospital, the Kedougou Health Center, the Bandafassi Clinic, 
the Military Health Centre, and the Catholic Mission, which 
has a mobile team that provides healthcare to indigenous popu-
lations in remote areas (Figure 2). Suspected CHIKV cases were 
defined as patients over 1 year of age with a fever over 38.5°C 
and at least 2 of the following clinical symptoms: headache, 
maculopapular cutaneous exanthema, eye pain, joint pain or 
injury, myalgia, fatigue, vomiting, dyspnea, diarrhea, jaundice, 
disorientation, and hemorrhagic manifestations.
Active Surveillance of Chikungunya Among Students’ Cohorts
Four primary schools in Kedougou Department were selected 
for active surveillance including the Ninefesha, Bandafassi, and 
Ngari primary schools and the Catholic Mission School with 
some boarding residents as well as daily attendees (students 
from villages around Kedougou city). Serum samples were 
obtained from students each year before and after the rainy sea-
son (May and November) and tested for arboviruses of interest 
in the region including CHIKV antibody testing. In addition, 
schools were visited twice a week to identify students reaching 
criteria for the “suspect case” definition. Students not attending 
during the weekly visit at school were visited in their household 
to check whether they even met the “suspect case” definition. 
Suspect students cases were sent to the health center involved 
in the study to perform a blood sample for CHIKV virological 
diagnostic testing.
Surveillance of Chikungunya Among Primates
The study focused on 3 species of monkeys in the Kedougou 
area that are considered potential reservoirs of arboviruses: 
African green monkeys ([AGMs] Chlorocebus sabaeus), Patas 
monkeys (Erythrocebus patas [EP]), and Guinea baboons 
(Papio papio [PP]). Monkey blood sampling was conducted 
during the dry season (January–May 2010) around temporary 
ponds around the villages of Silling, Bafoundou, and Ngari-
Sekoto (Figure  2). The monkeys were trapped in large cages 
baited with peanuts and anaesthetized with ketamine. Five 
milliliters of blood was collected and centrifuged, and the 
serum fraction was collected and stored at −20°C or −80°C 
until tested for antibody as described below. The capture date, 
location, age, sex, and weight for each captured monkey were 
systematically recorded.
Laboratory Analysis
Malaria Test
Human blood samples were tested by Giemsa-stained blood 
smears and rapid malaria tests kits for plasmodia [22].
Localities of catching Monkeys
Health facilities
Localities of sampling Mosquitoes
Kedougou Region
Figure 2. Map of Kedougou showing the sites sampled for Chikungunya surveillance during this study. Red circles indicates locations of monkey sampling, blue squares 
indicate health facilities, and green triangles show sites of mosquito sampling.
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Serology
Blood samples collected from patients, students, and primates 
were centrifuged and stored at −20°C until tested for antibody. 
Samples were tested for CHIKV by immunoglobulin (Ig)M 
antigen-capture enzyme-linked immunosorbant assay (ELISA). 
A  differential diagnosis of CHIKV infection among other 
arboviruses such as yellow fever virus, dengue virus (DENV), 
West Nile virus, Rift Valley fever virus, and Crimean-Congo 
hemorrhagic fever virus, which are endemic in the study area, 
was also performed by IgM antibody-capture ELISA. Monkey 
serum samples were analyzed for specific CHIKV-neutralizing 
antibodies by plaque reduction neutralization tests (PRNTs) as 
described by De Madrid and Porterfield [23].
Molecular Detection
Real-time polymerase chain reaction (rPCR) was used to test 
human sera and mosquito samples for CHIKV. The mosquito 
sampling and testing protocols were extensively describes by 
Diallo et al 2012 [24].
Sequencing of E1 Coding Region
The whole genome of CHIKV strains was initially amplified 
using the Titan One Tube RT-PCR system (Roche, Mannheim, 
Germany), following the strategy reported by Volk et al [25]. Due 
to the extremely low level of variation in initially assessed genome 
sequence (data not shown), only the region that corresponded 
to the E1 envelope glycoprotein gene was subjected to further 
sequencing and analyses [2]. Primer sequences and specific PCR 
and sequencing protocols are available from the authors.
Phylogenetic Analysis
Genome sequences representing the spatiotemporal distribu-
tion of CHIKV were downloaded from GenBank and aligned 
using MUSCLE [26] and manually adjusted in Se-Al (available at 
http://tree.bio.ed.ac.uk/software/seal/) according to amino acid 
sequence homology. The E1 region was then excised and com-
bined with the 34 newly generated CHIKV E1 sequences, leading 
to a final data set containing 103 sequences and 1317 nucleotides. 
A maximum likelihood tree was then inferred using the PAUP 
v4.0b package [27], based on the best-fit nucleotide substitution 
model determined by MODELTEST [28]. The database and 
operation script is available upon request from the authors.
Statistical Analysis
Data were analyzed using R software. The χ2 test was used to 
compare the difference between 2 proportions, with a statistical 
significance level set at P < .05.
RESULTS
Patient Samples
One thousand four hundred nine suspect cases of CHIKV were 
evaluated from 5 healthcare facilities in Kedougou between May 
2009 and March 2010 and tested for evidence of acute CHIKV 
infection using virus isolation, viral genome, or IgM antibody 
detection. Table 1 summarizes the distribution of findings relating 
to human sera collected, 50.4% of which were negative for active 
malaria parasitemia. Overall, evidence for CHIKV infection was 
observed in 1.4% (20 of 1409)  of patients including 6 patients 
who tested positive for CHIKV-specific IgM antibody (Table 1). 
Among the 1409 human sera sampled, 144 were referred to acute 
stage injury (<5 days of illness) and subsequently tested for CHIKV 
detection or for viral genetic material evidence. Hence, CHIKV rib-
onucleic acid (RNA) was detected by rPCR in 9.7% (14 of 144) of 
patients. Of note, the majority of CHIKV-confirmed cases based on 
the detection of virus or viral RNA from acute sera (9 of 14; 64 %) 
were recruited from the Kedougou healthcare center (Table 1).
In terms of the spatial distribution and among the 20 con-
firmed humans cases, 90% were reported in the Kedougou 
district, suggesting an incidence rate ranging from 0.55 to 
9.38/1000 inhabitants, and 10% (2 of 20) of cases were reported 
in the Saraya district (Table  1), with an incidence rate at 
1.34/1000 inhabitants.
The median age of infected patients was 24  years (7–55), 
the sex ratio male/female was 1.  Adult individuals, especially 
those between 31 and 45  years old, were significantly more 
affected than others. However, there was no significant differ-
ence between sexes (P > .05). The most common clinical symp-
toms among patients were headache (70%), myalgia (70%), and 
arthralgia (60%) followed by vomiting (30%), cough (25%), 
diarrhea (10%), and cutaneous rash (5%) (Figure 3A). Among 
the CHIKV-infected confirmed cases, 20% (4 of 20)  were 
diagnosed with malaria coinfection and presented with all the 
previously described symptoms except rash. Diarrhea and vom-
iting were more common in malaria coinfection (33% and 50%, 
Table 1. Enrolled Patients and CHIKV-Positive (+) Cases in Kedougou in Five Health Facilities From July 2009 to March 2010
Health Facilities No. Sera Collected No. CHIKV ELISA IgM+ No. Acute Sera Tested No. CHIKV rPCR+ Total Positive
Kedougou 319 0 47 9 9
Military Camp 658 5 40 0 5
Bandafassi 205 0 28 3 3
Ninefesha 199 1 29 2 3
Catholic Mission 28 0 0 0 0
Total 1409 6 144 14 20
Abbreviations: CHIKV, Chikungunya virus; ELISA, enzyme-linked immunosorbant assay; IgM, immunoglobulin M; rPCR, real-time polymearse chain reaction. 
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respectively) than in the sole CHIKV infection with no evidence 
of active malaria (6% and 25%) (Figure 3B). However, no signifi-
cant difference was observed in the frequency of signs and symp-
toms between the malaria and CHIKV-only groups (P > .50).
Analysis of temporal distribution of CHIKV-positive mos-
quito pools and CHIKV-infected cases showed an overlap 
between the 2, with a lag of approximately 1 month between the 
first detection of CHIKV-infected mosquitoes and first detec-
tion of a human case (Figure 4). The epidemic curve showed 
intermittent peaks that began in October 2009 with the first 
peak in week 2 (6 cases). In November 2009, the number of 
CHIKV-infected confirmed cases peaked in the first week 1 (6 
cases), and then declined gradually by half (3 cases per week) 
at weeks 2 and 3, and finally dropped to 1 case at week 4 of 
November 2009. No case was detected between December 2009 
and February 2010. In March 2010, 1 more confirmed CHIKV 
case was detected during the relating second week (Figure 4).
Entomological Findings
From June 2009 to January 2010, a total of 39 799 mosquitoes, 
grouped in 4211 pools, were collected and analyzed. The most 
abundant species among the potential CHIKV vectors were 
Aedes vittatus (23.0% of the host-seeking females), A furcifer 
(18.7%), Aedes dalzieli (15.6%), and A luteocephalus (13.1%). 
A  total of 42 CHIKV-infected pools were obtained by rPCR 
from September to December 2009 mainly from A furcifer (16 
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pools), A taylori (5 pools), and A luteocephalus (5 pools), which 
represented 66.9% of the CHIKV-positive pools.
Analysis of the E1 Sequences
As shown in Figure 5, all of our samples from 2009, including 
those from both mosquitoes and patients, were closely related 
to each other. All were within the West-Africa lineage, with a 
closest neighbor from Senegal in 2005. All of the CHIKV strains 
had an alanine residue at E1 position 226, consistent with enzo-
otic strains rather than the recent strains responsible of Asian or 
South American epidemics.
Active Surveillance Among School Children
A total of 866 students were investigated for CHIKV circula-
tion in May and November 2009 in 4 schools. Enzyme-linked 
immunosorbent assay (ELISA) IgM was performed on all 
sera collected. Table  3 shows that no evidence of recent 
CHIKV infection was detected in May. However, ELISA 
IgM performed on sera collected from the same children in 
November 2009 showed that 25 were positive for CHIKV in 
Bandafassi, Ninefesha, and Catholic Mission schools with 
infection rates of 4% (7 of 171), 8% (15 of 180), and 0.6% 
(3 of 464), respectively. The infection rates were significantly 
different among the schools (P < .000003; Fisher’s exact test). 
However, in Bandafassi and Ninefesha schools, the infec-
tion rate was statistically similar (P = .12; Fisher’s exact test). 
Between November 2009 and May 2010, a total of 65 sus-
pected students were followed. However, none was positive 
for CHIKV test.
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Primates Samples Analysis
One hundred seventeen monkeys including 77 PP, 33 
Chlorocebus sabaeus (AGM), and 7 EP were sampled from 
March to May 2010 in Silly, Ngari, and Bafoundou (Figure 1). 
No IgM antibody-positive animals were detected, but 
CHIKV-neutralizing antibodies were found by PRNT in 87% 
(66 of 76) of PP, 75% (25 of 33) of AGM, and 71% (5 of 7)   
of EP; 34% of infant and juvenile primates had neutraliz-
ing antibodies. Chikungunya virus seroprevalences did not 
differ significantly among the 3 primates species (P  >  .22; 
Fisher’s exact test).
DISCUSSION
Chikungunya virus is a re-emerging mosquito-borne viral 
infection. In the Kedougou region, Southeastern Senegal, sev-
eral epizootics of CHIKV have been reported at intervals of 
approximately 5 years since 1972, but little information is avail-
able on the impact of CHIKV among human populations and 
mechanisms involved in its emergence. In the present study, we 
reported a sylvatic outbreak of CHIKV in the Kedougou region 
that was evidenced from patients recruited in 5 health facilities 
and among a prospective cohort of living locally students.
Overall, a combination of serological IgM, rPCR testing, and 
virus isolation performed on 1409 patients enrolled revealed 20 
that were infected by CHIKV in the survey area. Seventy per-
cent of CHIKV-positive patients had symptoms matching the 
case CHIKV disease definition. This result is similar to that 
reported during CHIKV epidemics that occurred in Thailand 
[29] and in the Indian Ocean [30]. Overall, the clinical manifes-
tations observed (algo-febrile eruptive illness, with vomiting and 
diarrhea) were similar to those described previously for acute 
CHIKV infection [11]. Our study also revealed coinfections of 
CHIKV with malaria in 20% of CHIKV-confirmed cases and 
supporting previous observations on CHIKV-malaria coinfec-
tions reported in the Democratic Republic of the Congo and 
in Senegal [31, 32]. Except for the absence of cutaneous rash, 
the coinfected patients presented the same symptoms and signs 
described above for CHIKV-only infection. Diarrhea and vom-
iting were more frequently reported among confirmed malaria 
cases coinfected with CHIKV, but no significant difference was 
observed when comparing with patients infected with CHIKV 
only. These results (1) underscore the difficulties and challenges 
in clinically differentiating these conditions in areas where 
malaria is endemic [3] and (2) reinforce malaria as an “umbrella” 
infection potentially masking arboviral disorders in the context 
of sub-Saharan Africa. Therefore, in suspected cases of malaria, 
CHIKV infection should be included as an alternative diagno-
sis, as well as other arboviral infection options. As previously 
described, fever and joint involvement were the most frequent 
manifestations, affecting most of Chikungunya patients [11, 30]. 
Also our study showed that 60% of infected patients presented 
arthralgia for which 10% experienced persistent arthralgia.
Our finding of equal prevalence of CHIKV infection between 
the genders and the age groups is also consistent with a rural 
outbreak of CHIKV that occurred in Cameroon [33]. In con-
trast to studies carried out in Nigeria in the 1960s–1970s, 
where children from 1 to 4 years of age were significantly more 
infected [34, 35], all age groups were found to be to be suscep-
tible for infection with CHIKV. Distinctly, an exception for 
children under 4  years was noteworthy, suggesting that little 
or no domestic transmission of CHIKV occurred during this 
outbreak. Indeed, children younger than 4  years of age tend 
to remain in the household, unlike adults and schoolchildren 
Table  2. Spatial Distribution, Gender, and Age Distribution of CHIKV-
Positive (+) Cases in Kedougou From July 2009 to March 2010
Localities
Recruited 
Patients
Population
CHIKV+
District Number % Number IRa (1/1000)
Bandafassi 94 6.67 972 1 1.028
Boundoucondi 16 1.13 177 1 5.64
Ibel 17 1.20 1000 1 1
Thioketian 17 1.20 512 1 1.953
Niemeneke 1 0.07 800 1 1.25
Ninefesha 34 2.41 213 2 9.38
Kedougou 834 59.19 19 731 11 0.55
Others 394 27.96 0 0
Subtotal 1407 99.85 23 405 18 0.769
Sabadola 2 0.15 1454 2 1.375
Total 1409 100 25 859 20 0.804
Sex
Male 747 53 11933 10 0.838
Female 661 47 12926 10 0.773
Age Group
0–4 years 165 11.71 4227 0 0
5–14 years 494 35.06 6960 6 0.862
15–29 years 427 30.30 6960 5 0.718
30–44 years 194 13.76 3729 6 1.609
>45 years 106 7.54 2983 3 1.005
Missing 23 1.63 — — —
Total 1409 100.00 24859 20 0.804
Abbreviations: CHIKV, Chikungunya virus; IR, incidence rate. 
Table  3. Number of Student Samples Tested and Number of Students 
Positive (+) by ELISA IgM Against CHIKV in May and November 2009
School Number Students
CHIKV+
May 2009 November 2009
Bandafassi 171 0 7
Ninefesha 180 0 15
Ngari 51 0 0
Catholic Mission 464 0 3
Total 866 0 25
Abbreviations: CHIKV, Chikungunya virus; ELISA, enzyme-linked immunosorbant assay; 
IgM, immunoglobulin M. 
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(7 years old and older) whose activities (agriculture, traditional 
gold extraction) and daily school attendance from remote vil-
lages expose them to forests and forest-living mosquitoes.
Our data also showed low CHIKV incidence rates (0.55–
9.38/1000), in comparison with those reported from Kaffrine 
(with an incidence rate of 35.3%), Senegal in 1996–1997 [3] and 
on the Maldive islands (65.2/1000) [36]. This observation may 
be explained by the low density of the human population in 
Kedougou, which is 8 people/km2 and probably not sufficient for 
human-mosquito-human CHIKV transmission. Previous stud-
ies showed that human population densities of approximately 
3000–7000/km2 are needed to produce CHIKV outbreaks [37]. 
It is also likely that only severe cases attend healthcare centers 
and clinics, and the asymptomatic forms of the disease—which 
is believed to be a vast majority of cases—were missed by the 
recruitment process used in this investigation.
Among the cohort of schoolchildren, 25 seroconverted for 
CHIKV IgM antibody in Bandafassi, Ninefesha, and Catholic 
Mission schools between May and November 2009, suggesting 
that CHIKV circulated during the rainy season. The infection 
rate was observed in students of Ninefecha and Bandafassi 
schools, which are located in the forest area. In addition, the con-
firmed CHIKV cases belonging to the Catholic Mission School 
(located in Kedougou city) were students who returned to their 
villages during week ends and holidays. Overall, the exposure 
of these students to CHIKV could be explained by their prox-
imity to the forest environment, which could facilitate con-
tact with CHIKV-infected mosquito vectors. This explanation 
is further strengthened by the level of difference for infection 
rates between the student cohort (2.88%) and the framework of 
the local healthcare facilities (1.42%). Furthermore, up to 36% 
of the CHIKV patients found in the Kedougou area were evi-
denced with a history of recent travel to forested areas.
Chikungunya virus isolates obtained from humans and mos-
quitoes [24] were found between October and December 2009, 
confirming previous studies showing that in the Kedougou area 
arboviruses are mostly isolated from October to December, 
which corresponds to the end of the rainy season [18, 19]. 
Chikungunya virus was mostly isolated from A furcifer, which 
is probably the primary vector of this outbreak. In a companion 
study [24], we showed that A furcifer occurred in all 5 major 
land cover classes in the Kedougou region (forest, village, agri-
culture, savannah, and barren). On this behalf, there were no 
significant differences in the abundance of this species among 
these land cover classes, and the A furcifer species was rarely 
found inside households in villages and was distinctly more 
abundant on the periphery than inside the villages. In addition, 
CHIKV was also detected at equal rates in all 5 lands cover 
classes. Given that, humans are rarely staying in forests during 
the moment when sylvatic CHIKV vectors are the more active. 
Because A furcifer shows high biting rates in villages [24], we 
suggest that humans are likely exposed to sylvatic CHIKV 
while outside of their homes but within their villages. Such an 
hypothesis is reinforced by the fact that no domestic transmis-
sion of CHIKV occurred given the absence of infection among 
children under 4  years, who are more likely to spend time 
within the household. Our results also suggest that the CHIKV 
epizootic began in September 2009. Hence, sylvatic circulation 
must precede epidemic amplification in the emergence area 
[38, 39]. The CHIKV outbreak episode that emerged in March 
2010 raises a question about the transmission of the virus 
during the dry season in southeastern Senegal. Based in our 
data, the Anopheles genus found infected with CHIKV could 
be partly involved in transmission, consistent with a previous 
study that demonstrated experimental CHIKV transmission by 
Anopheles spp [40].
The sylvatic CHIKV cycle in Senegal is believed to be main-
tained through the nonhuman primates. We found evidence for 
past CHIKV infection in 3 monkey species collected between 
March and May 2010. Although sampling of primates occurred 
after our studies of humans and mosquitoes (May 2009 to 
March 2010), the detection of CHIKV-neutralizing antibodies 
among infant primates strongly suggest that they were proba-
bly infected recently during the sylvatic amplification between 
May and November 2009. Previous studies have shown that the 
turnover of monkey populations is necessary for the emergence 
of arboviruses [41].
As shown in our phylogenetic tree (Figure  5), the CHIKV 
strains isolated from patients in Kedougou in 2009 clustered 
in the West African genotype and were closely related to pre-
vious isolates from Senegal, suggesting continuous circulation 
of CHIKV in rural or sporadic local transmission of the virus. 
The isolates sequenced exhibited an alanine at amino acid resi-
due 226 of the E1 envelope glycoprotein. Previous studies have 
demonstrated that a substitution of valine (A226V) provides 
a selective advantage for the replication and transmission of 
CHIKV by A albopictus [42, 43]. However, no A albopictus was 
detected so far in the study area, in Senegal and in turn in West 
Africa. Our phylogenetic data supported by the sylvatic ampli-
fication of CHIKV described by Diallo et al [24], are similar to 
previously studies based on DENV, which suggest that sylvatic 
cycle is a natural source of emergence [20, 44].
CONCLUSIONS
In conclusion, the present study highlights the importance of 
surveillance including clinical observations, laboratory diag-
nosis, and cohort serosurveillance to detect outbreaks caused 
by CHIKV and other arboviruses in the Kedougou region. The 
combination of serological and molecular tests identified an 
epidemic of CHIKV in Kedougou after an amplification from 
the sylvatic cycle that would otherwise have been overlooked. 
Our results support the hypothesis that sylvatic enzootic circu-
lation can be a source of emergence of CHIKV into domestic or 
urban transmission cycles and underscore the value of effective, 
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real-time surveillance to improve the detection and prevention 
of arboviral diseases.
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